Yacton and mexicor influence on prooxidant-antioxidant homeostasis and protein synthesis in the myocardium of rats in conditions of doxorubicin cardiomyopathy
DOI:
https://doi.org/10.14739/2310-1210.2015.2.42016Keywords:
Yacton, Mexicor, Homeostasis, ProteinsAbstract
Doxorubicin, which is included in the scheme of cancer treatment, possesses cardiotoxicity that requires effective cardioprotectors searching.
Aim. The aim of the study was to compare the influence of yacton and mexicor on the antioxidant system, oxidative modification of proteins, protein synthesis in the myocardium of rats in conditions of doxorubicin cardiomyopathy.
Methods and results. The content of prooxidant-antioxidant homeostasis indicators - SOD, GPR, GR, AFG, KFG and proteinsynthesis – the protein content in the cytoplasma and mitochondria and protective effect of derivatives of succinic acid (yacton, mexicor) were studied in the myocardium of rats in the conditions doxorubicin cardiomyopathy with wellknown methods.
Conclusion. It is stated that yakton similar to mexicor has protective influence on the prooxidant-antioxidant homeostasis, protein synthesis in the rats myocardium in conditions of doxorubicin cardiomyopathy.
References
Fyliak, O. S., Fyliak, Ye. S., & Toika, R. S. (2005) Vplyv doksorubitsynu na fosforyliuvannia bilka SMAD3 zadiianoho u syhnalnomu shliakhu transformuiuchoho faktora rostu S3 u klitynakh linii A549 kartsynomy leheniv liudyny [Effect of doxorubicin on phosphorylation of protein SMAD3 which is involved into signaling pathway of transforming growth factor β in human lung carcinoma A549 cells]. Medychna khimiia, 7(1), 52–62. [in Ukrainian].
Hrelia, S., Fiorentini, D., Maraldi, T., Angeloni, C., Bordoni, A., Biagi, P. L., & Hakim, G. (2002) Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim. Biophys. Acta, 1567(1–2), 150–156.
Kovalenko, V. N., Kalinkina, N. V., & Vatutin, N. T. (2002) Povrezhdenyia serdca citostatikami [Heart damage by cytostatics]. Doneck. [in Ukrainian].
Trofimova, T. S., Chekman, I. S., Horchakova, N. O., & Avramenko, M. O. (2004) Kardiotoksychnist doksorubitsynu ta shliakhy korektsii tiotryazolinom [Doxorubicin cardiotoxicity and path ways of its correction by thiotriazolin]. Zaporozhskij medicinskij zhurnal, 5, 153–155. [in Ukrainian].
Chekman, I. S., Horchakova, N. O., Nahorna, O. O., & Nebesna, T. Yu. (2008) Nikotynamid [Nicotinamide]. Kyiv: Polihrafplius. [in Ukrainian].
Yakovleva, I. Yu., & Belenichev, I. F. (2009) Neiroprotektyvna diia yaktonu [Neuroprotective action of yakton]. Visnyk problem biolohii i medytsyny, 1, 145–150. [in Ukrainian].
Maksimchuk, E. A., Gorchakova, N. A., & Chekman, І. S. (2009) Mekhanizmy razvitiya kardiotoksichnosti doksorubicina i puti preduprezhdeniia [Mechanisms of doxorubicin cardiotoxicity and ways of prevention]. Naukovyi visnyk Natsionalnoho medychnoho universytetu imeni O.O. Bohomoltsia, 4, 275–279. [in Ukrainian].
Korokin, M. V., Pokrovskij, M. V., Konovalova, E. A., Savvin, V. A., Honcharov, N. F., Denisiuk, T. A., et al. (2012) Vozmozhnosti farmakologicheskoj korrekcii endotelial`noj disfunkcii y koronarnogo krovotokа s pomoshchyu mildronata i meksikora [Possible pharmacological correction of endothelial dysfunction and coronary blood flow with mildronate and mexicor]. Nauсhnye vedomosti Belgorodskogo gosudarstvennogo universiteta, 4(123), 189–197. [in Russian].
Chekman, I. S., Gubskij, Yu. I., Hromov, L. A., Belenichev, I. F. (2010) Doklinicheskoe izuchenie specificheskoj aktivnosti potencial`nykh nejroprotektivnykh preparato [Preclinical study of the potential neuroprotective drugs specific activity]. Kiev. [in Ukrainian].
Chekman, I. S., Gorchakov, N. A., Francuzova, S. B., & Nagornaya, E. A. (2009) Metabolicheskie i metabolitotropnye preparaty v sisteme kardio- i orghanoprotekcii [Metabolic and metabolitotropic drugs in the system of cardio and organoprotection]. Kiev: Poligrafplyus. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)